AI-generated summary
The authors studied 63 patients with non-seasonal major depression who received sertraline with either bright or dim light therapy for five weeks. Saliva cortisol was measured before treatment began to calculate the cortisol awakening response. The authors report that patients with a low response benefited substantially more from bright light than from dim light, while patients with a high response showed no such benefit.
- Participants
- 63
- Who or what was studied
- Patients with non-seasonal major depression treated with sertraline plus bright or dim light therapy
- Limits stated in the abstract
- The abstract does not describe the study's size, controls or randomization beyond the single group of 63 patients, and it does not report wavelengths or light intensity.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.